Akebia Ther

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.87-$4.07
Market Cap
$273.6M
Shares Short
26M

Financials

See more
Revenue (12 Mos)
$232.4M
Revenue Growth (YoY)
-6.6%
Gross Profit (12 Mos)
$190.4M
Diluted EPS
-$0.08

News

See more

Yahoo Finance • 24 days ago

Akebia outlines Phase II FSGS study of up to ~60 patients as Vafseo reaches nearly 7,500 patients

Yahoo Finance • 24 days ago

Akebia plunges 20% on muted Q1 print

Yahoo Finance • 24 days ago

Akebia Therapeutics Q1 Earnings Call Highlights

Yahoo Finance • last month

Germany Anemia Treatment Market Forecast and Company Analysis Report 2026-2034 Featuring Akebia Therapeutics, GSK, Vertex, Pfizer, Sanofi, Takeda, Novartis, Johnson & Johnson, Roche, Biocon Biologics

About

CEO
Mr. John P. Butler MBA
CFO
Mr. Erik John Ostrowski M.B.A.
Address
245 First Street, Cambridge, MA, United States, 02142
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-Time Employees
194